GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Net Margin %

Waverley Pharma (TSXV:WAVE) Net Margin % : -2,722.45% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Waverley Pharma's Net Income for the three months ended in Dec. 2023 was C$-1.33 Mil. Waverley Pharma's Revenue for the three months ended in Dec. 2023 was C$0.05 Mil. Therefore, Waverley Pharma's net margin for the quarter that ended in Dec. 2023 was -2,722.45%.

The historical rank and industry rank for Waverley Pharma's Net Margin % or its related term are showing as below:

TSXV:WAVE' s Net Margin % Range Over the Past 10 Years
Min: -637.22   Med: -79.13   Max: -45.46
Current: -538.74


TSXV:WAVE's Net Margin % is ranked worse than
65.66% of 1028 companies
in the Biotechnology industry
Industry Median: -154.79 vs TSXV:WAVE: -538.74

Waverley Pharma Net Margin % Historical Data

The historical data trend for Waverley Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Net Margin % Chart

Waverley Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -105.01 -51.35 -45.46 -53.25 -539.81

Waverley Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -115.64 -285.71 -161.74 -322.92 -2,722.45

Competitive Comparison of Waverley Pharma's Net Margin %

For the Biotechnology subindustry, Waverley Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waverley Pharma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Waverley Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Waverley Pharma's Net Margin % falls into.



Waverley Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Waverley Pharma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-2.224/0.412
=-539.81 %

Waverley Pharma's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.334/0.049
=-2,722.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waverley Pharma  (TSXV:WAVE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Waverley Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Waverley Pharma (TSXV:WAVE) Business Description

Traded in Other Exchanges
Address
1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.
Executives
Albert David Friesen 10% Security Holder, Director, Senior Officer